mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.4 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.4 |